Abbott leads $45M round for California-based medical device startup

In addition to the investment, Abbott has entered into a commercial agreement with Bigfoot to develop and commercialize diabetes management programs that integrate with its glucose sensing technology.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.